These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31029757)

  • 1. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.
    Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D
    J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis.
    Yi M; Li Q; Zhao Y; Nie S; Wu N; Wang D
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):340-349. PubMed ID: 31474470
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhao L; Qiu X; Wang R; Wang D
    J Pharm Biomed Anal; 2021 Feb; 195():113869. PubMed ID: 33401116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the compatibility effects of Danggui-Sini Decoction on a blood stasis syndrome rat model using untargeted metabolomics.
    Wu JX; Zheng H; Yao X; Liu XW; Zhu HJ; Yin CL; Liu X; Mo YY; Huang HM; Cheng B; Wu F; Chen ZN; Song FM; Ruan JX; Zhang HY; Liu P; Liang YH; Song H; Guo HW; Su ZH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():164-175. PubMed ID: 30594827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
    Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
    J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of Xue Fu Zhu Yu prescription for hyperlipidemia: A meta-analysis of randomized controlled trials.
    Wang S; Qiu XJ
    Complement Ther Med; 2019 Apr; 43():218-226. PubMed ID: 30935534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomics-based reveals the treatment mechanism of ShenGui capsule for application to coronary heart disease in a rat model.
    Wang D; Guo J; Liu T; Zhou X; Yang Z; Shi C; Wang W; Li R; Zhang Y; Junzhang ; Yan J; Zhu X; Li Y; Gong M; Cui Y; Wu X
    Anal Biochem; 2022 Apr; 642():114480. PubMed ID: 34813769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
    Ji H; Liu Y; He F; An R; Du Z
    J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
    Shi S; Liu Z; Xue Z; Chen X; Chu Y
    J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Profiling Analysis of Patients With Coronary Heart Disease Undergoing Xuefu Zhuyu Decoction Treatment.
    Tao T; He T; Wang X; Liu X
    Front Pharmacol; 2019; 10():985. PubMed ID: 31551786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and antioxidative effects of Dan-Lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies.
    Li Z; Yang L; Liu Y; Xu H; Wang S; Liu Y; Zhao H; Xie J; Gao S; Gao S; Xu Y; Li L; Li Y; Yu C
    J Ethnopharmacol; 2019 Aug; 240():111911. PubMed ID: 31034953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
    He H; Chen G; Gao J; Liu Y; Zhang C; Liu C; Li H; He Q; Li J; Wang J
    Trials; 2018 Sep; 19(1):515. PubMed ID: 30241562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Serum Metabonomics and Formula-Pattern Correspondence in Coronary Heart Disease Patients Diagnosed as Phlegm or Blood Stasis Pattern Based on Ultra Performance Liquid Chromatography Mass Spectrometry.
    Lu XY; Xu H; Zhao T; Li G
    Chin J Integr Med; 2018 Dec; 24(12):905-911. PubMed ID: 29948595
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and quantification of major constituents of Xue Fu Zhu Yu by UPLC-DAD-MS/MS.
    Zhang L; Zhu L; Wang Y; Jiang Z; Chai X; Zhu Y; Gao X; Qi A
    J Pharm Biomed Anal; 2012 Mar; 62():203-9. PubMed ID: 22264846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.
    Wang WR; Lin R; Zhang H; Lin QQ; Yang LN; Zhang KF; Ren F
    J Ethnopharmacol; 2011 Sep; 137(1):214-20. PubMed ID: 21605653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Metabolomics Analysis of Xueshuan Xinmaining Tablet in Blood Stasis Model Rats Using UPLC-Q/TOF-MS.
    Tan J; Wang C; Zhu H; Zhou B; Xiong L; Wang F; Li P; Liu J
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29986394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Strategy Using High Resolution Mass Spectrometry Reveals Novel Biomarkers and Pain-Relief Effect of Traditional Chinese Medicine Prescription Wu-Zhu-Yu Decoction Acting on Headache Modelling Rats.
    Liu R; Xu H; Zhang X; Wang X; Yuan Z; Sui Z; Wang D; Bi K; Li Q
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29258229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS.
    Liu M; Liu X; Wang H; Xiao H; Jing F; Tang L; Li D; Zhang Y; Wu H; Yang H
    J Ethnopharmacol; 2016 Mar; 180():1-11. PubMed ID: 26806568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.